Dividend Investing Ideas Center
Critical Facts You Need to Know About Preferred Stocks
Have you ever wished for the safety of bonds, but the return potential...
Rating
Sector Rating
Recommendation *
Avoid
Neutral
Fair
Quality
Rating Breakdown
Avg.
Relative Strength
The relative strength of a dividend stock indicates whether the stock is uptrending or not. The major determining factor in this rating is whether the stock is trading close to its 52-week-high.
Overall Yield Attractiveness
If a stock’s yield is above or near the market average then it will be rated higher within this parameter. High dividend yields (usually over 10%) should be considered extremely risky, while low dividend yields (1% or less) are simply not very beneficial to long-term investors.
Dividend Reliability
A stock’s dividend reliability is determined by a healthy payout ratio that is higher than other stocks. A company that pays out close to half its earnings as dividends and retains the other half of earnings has ample room to grow its business and pay out more dividends in the future.
Dividend Uptrend
A stock’s Dividend Uptrend rating is dependent on the company’s price-to-earnings (P/E) ratio to evaluate whether or not a stock’s dividend is likely to trend upward. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase.
Earnings Growth
A stock’s Earnings Growth rating evaluates a company’s expected EPS for the current financial year and compares it to next financial year’s expected EPS. Stocks with single-digit growth estimates will have a higher rating than others, as our research has shown that well-established dividend-paying companies have modest earnings growth estimates.
You take care of your investments. We like that.
Upgrade to Premium to access your Watchlist and more.
The Cannabis ETF
ETF
THCX
Payout Change
Suspended
Price as of:
$3.45
+0.15
+4.55%
primary theme
Sector Diversified Equity
THCX (ETF)
The Cannabis ETF
Payout Change
Suspended
Price as of:
$3.45
+0.15
+4.55%
primary theme
Sector Diversified Equity
THCX (ETF)
The Cannabis ETF
Payout Change
Suspended
Price as of:
$3.45
+0.15
+4.55%
primary theme
Sector Diversified Equity
Name
Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
-59.6%
1 yr return
-62.6%
3 Yr Avg Return
-33.7%
5 Yr Avg Return
N/A
Net Assets
$41.2 M
Holdings in Top 10
57.8%
52 WEEK LOW AND HIGH
$3.3
$2.75
$10.05
Expenses
OPERATING FEES
Expense Ratio 0.75%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 54.09%
Redemption Fee N/A
Min Investment
Standard (Taxable)
N/A
IRA
N/A
Fund Classification
Fund Type
Exchange Traded Fund
Investment Style
Miscellaneous Sector
Name
Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
THCX - Profile
Distributions
- YTD Total Return -59.6%
- 3 Yr Annualized Total Return -33.7%
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio -0.25%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameThe Cannabis ETF
-
Fund Family NameInnovation Shares
-
Inception DateJul 09, 2019
-
Shares OutstandingN/A
-
Share ClassN/A
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerMichael Obuchowski
Fund Description
The fund will invest at least 80% of its total assets in the component securities of the index. It will also invest, under normal circumstances, at least 80% of its net assets, plus borrowings for investment purposes, in exchange listed common stock (or corresponding American Depositary Receipts ("ADRs") of Cannabis Companies. The index is a proprietary, rules-based index designed to track the performance of a portfolio of Cannabis Companies. The fund is non-diversified.
THCX - Performance
Return Ranking - Trailing
| Period | THCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -59.6% | -59.6% | 27.3% | 100.00% |
| 1 Yr | -62.6% | -68.1% | 24.3% | 93.48% |
| 3 Yr | -33.7%* | -40.9% | 43.4% | 92.31% |
| 5 Yr | N/A* | -24.2% | 29.9% | N/A |
| 10 Yr | N/A* | -1.2% | 21.9% | N/A |
* Annualized
Return Ranking - Calendar
| Period | THCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2021 | -31.7% | -39.3% | 28.3% | 97.67% |
| 2020 | 2.1% | -16.6% | 82.7% | 70.00% |
| 2019 | N/A | -31.4% | 35.7% | N/A |
| 2018 | N/A | -23.4% | 1.6% | N/A |
| 2017 | N/A | -1.4% | 34.6% | N/A |
Total Return Ranking - Trailing
| Period | THCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| YTD | -59.6% | -73.0% | 27.3% | 96.67% |
| 1 Yr | -62.6% | -68.1% | 24.3% | 93.48% |
| 3 Yr | -33.7%* | -40.9% | 43.4% | 92.31% |
| 5 Yr | N/A* | -24.2% | 29.9% | N/A |
| 10 Yr | N/A* | 1.1% | 21.9% | N/A |
* Annualized
Total Return Ranking - Calendar
| Period | THCX Return | Category Return Low | Category Return High | Rank in Category (%) |
|---|---|---|---|---|
| 2021 | -31.7% | -39.3% | 28.3% | 97.67% |
| 2020 | 2.1% | -16.6% | 82.7% | 70.00% |
| 2019 | N/A | -31.4% | 35.7% | N/A |
| 2018 | N/A | -23.4% | 1.6% | N/A |
| 2017 | N/A | -1.4% | 34.6% | N/A |
THCX - Holdings
Concentration Analysis
| THCX | Category Low | Category High | THCX % Rank | |
|---|---|---|---|---|
| Net Assets | 41.2 M | 610 K | 31.2 B | 56.90% |
| Number of Holdings | 27 | 1 | 389 | 91.18% |
| Net Assets in Top 10 | 23.7 M | -21.4 M | 5.86 B | 52.94% |
| Weighting of Top 10 | 57.76% | 8.9% | 100.0% | 35.94% |
Top 10 Holdings
- Aphria Inc 7.56%
- AFC Gamma Inc Ordinary Shares 7.46%
- Cronos Group Inc 6.68%
- Aurora Cannabis Inc 6.53%
- Tilray Brands Inc 6.22%
- WM Technology Inc Ordinary Shares - Class A 5.58%
- Leafly Holdings Inc 5.53%
- Fire & Flower Holdings Corp Ordinary Shares 5.47%
- OrganiGram Holdings Inc 5.40%
- Amyris Inc 5.04%
Asset Allocation
| Weighting | Return Low | Return High | THCX % Rank | |
|---|---|---|---|---|
| Stocks | 100.00% | 0.00% | 100.33% | 20.59% |
| Preferred Stocks | 0.00% | 0.00% | 29.02% | 88.24% |
| Other | 0.00% | -8.90% | 91.95% | 86.76% |
| Convertible Bonds | 0.00% | 0.00% | 3.05% | 88.24% |
| Cash | 0.00% | -0.34% | 101.46% | 91.18% |
| Bonds | 0.00% | 0.00% | 88.23% | 88.24% |
Stock Sector Breakdown
| Weighting | Return Low | Return High | THCX % Rank | |
|---|---|---|---|---|
| Healthcare | 65.82% | 0.00% | 100.00% | 5.08% |
| Real Estate | 7.46% | 0.00% | 54.95% | 18.64% |
| Consumer Defense | 6.65% | 0.00% | 53.62% | 27.12% |
| Basic Materials | 6.29% | 0.00% | 36.59% | 28.81% |
| Technology | 5.58% | 0.00% | 77.79% | 66.10% |
| Industrials | 4.38% | 0.00% | 90.47% | 61.02% |
| Consumer Cyclical | 3.82% | 0.00% | 41.11% | 62.71% |
| Utilities | 0.00% | 0.00% | 85.14% | 89.83% |
| Financial Services | 0.00% | 0.00% | 95.51% | 91.53% |
| Energy | 0.00% | 0.00% | 32.10% | 89.83% |
| Communication Services | 0.00% | 0.00% | 16.38% | 91.53% |
Stock Geographic Breakdown
| Weighting | Return Low | Return High | THCX % Rank | |
|---|---|---|---|---|
| US | 56.20% | 0.00% | 85.31% | 39.71% |
| Non US | 43.80% | 0.00% | 98.35% | 35.29% |
THCX - Expenses
Operational Fees
| THCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Expense Ratio | 0.75% | 0.22% | 4.26% | 48.00% |
| Management Fee | 0.95% | 0.25% | 1.90% | 84.29% |
| 12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
| Administrative Fee | N/A | 0.03% | 0.19% | N/A |
Sales Fees
| THCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Front Load | N/A | 0.00% | 5.75% | N/A |
| Deferred Load | N/A | 1.00% | 2.25% | N/A |
Trading Fees
| THCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Max Redemption Fee | N/A | 2.00% | 2.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
| THCX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
|---|---|---|---|---|
| Turnover | 54.09% | 0.00% | 140.00% | 76.47% |
THCX - Distributions
Dividend Yield Analysis
| THCX | Category Low | Category High | THCX % Rank | |
|---|---|---|---|---|
| Dividend Yield | 0.00% | 0.00% | 9.73% | 93.33% |
Dividend Distribution Analysis
| THCX | Category Low | Category High | Category Mod | |
|---|---|---|---|---|
| Dividend Distribution Frequency | Annually | Annually | Quarterly | Semi-Annually |
Net Income Ratio Analysis
| THCX | Category Low | Category High | THCX % Rank | |
|---|---|---|---|---|
| Net Income Ratio | -0.25% | -2.66% | 5.19% | 69.09% |
Capital Gain Distribution Analysis
| THCX | Category Low | Category High | Capital Mode | |
|---|---|---|---|---|
| Capital Gain Distribution Frequency | Annually | Annually | Annually |
Distributions History
| Date | Amount | Type |
|---|---|---|
| Jul 01, 2021 | $0.003 | OrdinaryDividend |
| Jan 04, 2021 | $0.048 | OrdinaryDividend |
| Sep 22, 2020 | $0.150 | OrdinaryDividend |
| Jun 23, 2020 | $0.250 | OrdinaryDividend |
| Jan 02, 2020 | $0.418 | OrdinaryDividend |
THCX - Fund Manager Analysis
Managers
Michael Obuchowski
Start Date
Tenure
Tenure Rank
Jul 09, 2019
2.9
2.9%
Dr. Michael Obuchowski is the Founder and Chief Investment Officer of Merlin Asset Management (MAM). He founded MAM in June 2012 to continue developing and managing modern investment strategies. During the last 18 years, he developed a range of large and SMID cap growth equity focused investment strategies with the longest GIPS track record starting at the end of 2012 when Dr. Obuchowski provided investment advisory services through North Shore Asset Management (NSAM). From February 2014 to August 2016, Dr. Obuchowski provided investment advisory services through CONCERT Wealth Management, Inc., where he was a Portfolio Manager and member of the Investment Committee. In August 2018, Merlin Asset Management registered with the SEC as an independent Investment Advisor. Before NSAM, in July 2008, Dr. Obuchowski helped establish First Empire Asset Management, Inc. (FEAM). As FEAM's Chief Investment Officer, he was responsible for the development and management of all equity-related investment strategies. While at FEAM, Dr. Obuchowski developed a range of top-ranked large-cap growth equity investment strategies. His FEAM50 strategy was ranked by Informa Investments Solutions PSN as one of the Top Gun Bull & Bear Master large-cap growth equity strategies for a 3-year return as of 6/30/2011. The same strategy was also ranked in Lipper's Top 40 Money Managers for 12 quarters ending 12/31/2010, 3/31/2011, and 6/30/2011. Before joining FEAM, he was a co-founder, Principal, and Portfolio Manager at Altanes Investments, LLC, a New York City-based boutique investment advisory company specializing in the large-capitalization US and global diversified investment strategies. At Altanes Investment, Dr. Obuchowski was responsible for the development and management of investment strategies, portfolio management, trading, compliance, and operations. Before moving to finance, Dr. Obuchowski spent 15 years in academic research in healthcare and biotechnology. He was an Assistant Professor of Psychiatry at the Albert Einstein College of Medicine in New York, Chief of Psychophysiology Unit at the Psychiatry Research Division at Hillside Hospital, and Associate Director of the Recognition and Prevention Program at Schneider Children's Hospital in Glen Oaks, NY.
Tenure Analysis
| Category Low | Category High | Category Average | Category Mode |
|---|---|---|---|
| 0.75 | 23.1 | 6.77 | 3.29 |
